Research and business strategy across text, image, audio and multimodal AI products. Designed for multimodal ai product teams; creative-tech companies; investors; scoped around source evidence and specific commercial or operational decisions.
Generative AI and multimodal models is assessed through a defined research question rather than a generic claim of expertise. The proposed scope is research and business strategy across text, image, audio and multimodal ai products. Work starts with the decision to be supported, the accountable decision-maker and the records available for review. The project brief identifies assumptions, evidence quality, access limits, relevant time horizons and matters requiring independent specialist validation.
Inventory inputs and outputs by text, image, video, audio and structured data. For each modality document the model provider, required datasets, content moderation dependencies, retention settings and practical limits on attribution or provenance. A multi-model workflow can have different risk owners for each component.
Separate copyright and contract questions, rights in source material, licensing of input datasets, terms of model providers and rights allocated to customers. Map what can be established from published license terms, what needs factual disclosure and what requires a jurisdiction-specific professional assessment.
Compare product features and published generative-AI inventions by technical architecture and application, not brand positioning alone. The World Intellectual Property Organization’s 2026 GenAI patent update provides an external research reference; published family counts are landscape indicators, not proof of validity or infringement.
The following are illustrative research formats, not assertions that a particular engagement or deliverable has already been completed.
The technology patent landscape describes which evidence must be collected, its origin and review status, applicable commercial assumptions and the open decisions. It is intended to be reviewed with the project sponsor, not accepted as a certification, legal ruling or claim of future performance. Final scope depends on available records and agreed confidentiality arrangements.
The model rights inventory describes which evidence must be collected, its origin and review status, applicable commercial assumptions and the open decisions. It is intended to be reviewed with the project sponsor, not accepted as a certification, legal ruling or claim of future performance. Final scope depends on available records and agreed confidentiality arrangements.
The deployment-readiness checklist describes which evidence must be collected, its origin and review status, applicable commercial assumptions and the open decisions. It is intended to be reviewed with the project sponsor, not accepted as a certification, legal ruling or claim of future performance. Final scope depends on available records and agreed confidentiality arrangements.
Identify the precise business or technical decision, relevant evidence owner, published standard or source version and unresolved assumptions. Compare alternative interpretations, document the limitations of available data and specify what must be reviewed before a claim can be relied upon.
Identify the precise business or technical decision, relevant evidence owner, published standard or source version and unresolved assumptions. Compare alternative interpretations, document the limitations of available data and specify what must be reviewed before a claim can be relied upon.
Identify the precise business or technical decision, relevant evidence owner, published standard or source version and unresolved assumptions. Compare alternative interpretations, document the limitations of available data and specify what must be reviewed before a claim can be relied upon.
Describe the problem, intended use, decision owner and territorial scope; agree which facts would change the decision.
Map public standards, original contracts, product specifications, data, stakeholder interviews and available records. Timestamp versions and permissions.
Test alternatives against explicit criteria such as cost, novelty, operational impact, implementation dependencies and review effort.
Produce a source-linked memorandum or matrix with assumptions, limitations, specialist referral points and practical follow-up decisions.
For generative ai and multimodal models, the distinction between a vendor statement, published research and independently checked deployment evidence is essential. A product demonstration, research prototype or specification should be described as such. A source comparison must also establish dates and versions; developments in AI and compute change rapidly. Where a buyer plans procurement or investment, the final record should distinguish vendor promises, validated tests and assumptions requiring diligence.
Do not infer infringement, ownership or safety certification from high-level research.
External links are starting points for dated primary-source review, not substitutes for issue-specific verification.
WIPO 2026 Technology SPARK — GenAI patent trends — read the source
Define the immediate decision, the relevant sources and stakeholders, the applicable time frame and the proposed evidence record. An initial scope may include generative modalities, licensing and content provenance, business models.
No. Do not infer infringement, ownership or safety certification from high-level research. Professional opinions, certifications and specialist assessments require separately qualified parties and supporting facts.
Share the specific question, intended decision, technology or commercial context, relevant geography and expected output. Avoid sending confidential material before an appropriate process is agreed.